Biography of Garry Menzel
Last update: January 31, 2024Career
Garry was Founding Board Director at Black Diamond Therapeutics, and Chief Financial Officer at DaVita. Garry Menzel joined Black Diamond Therapeutics in 2016. Garry served as President and Chief Executive Officer at Black Diamond Therapeutics.
Garry Menzel is currently- Director at Black Diamond Therapeutics - View - Black Diamond Therapeutics org chart
- Director at Stoke Therapeutics - View - Stoke Therapeutics org chart
- Non-Executive Director at Adaptimmune Therapeutics - View - Adaptimmune Therapeutics org chart
Create your alert
to follow the career of Garry Menzel.
Education
Garry Menzel has a Doctor of Philosophy in Biochemistry and Molecular Biology from University of Cambridge in 1994 and a Master of Business Administration from Stanford Business School in 1998.
They have also studied at University of Cambridge :
Find more alumni from University of Cambridge
They have also studied at Stanford Business School :
Find more alumni from Stanford Business School
More about Garry Menzel
Selected links
Do you need to know more about Garry Menzel? More results.
Participate
Social media
- Garry Menzel on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Garry Menzel
The colleagues of Garry Menzel
Company Colleagues
- At Black Diamond Therapeutics, Garry Menzel has 19 colleagues including Mark Velleca (CEO & Director), David Epstein (Director)…
- At Stoke Therapeutics, Garry Menzel has 18 colleagues including Edward Kaye (CEO & Director), Arthur Levin (Director)…
- At Adaptimmune Therapeutics, Garry Menzel has 18 colleagues including Adrian Rawcliffe (CEO & Director), Ali Behbahani (Director)…
Industry Colleagues
- In the Biotechnology industry, Garry Menzel has 30,263 colleagues in 2,283 companies located in 40 countries. 14,384 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Garry Menzel.
Get in Touch
and ask for Garry Menzel.
